Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation

In a step towards addressing India’s critical need for organ donors, Mankind Pharma Limited, one of India’s leading pharmaceutical companies, has launched its nationwide public awareness campaign “Angdaan Mahadaan”, with a goal of inspiring 1 crore Indians to pledge for organ donation.

The campaign was launched in the presence of transplant specialists and dignitaries from the National Organ and Tissue Transplant Organisation (NOTTO), who came together to raise public awareness, dispel myths and highlight the transformative impact of organ donation.

Through “Angdaan Mahadaan”, Mankind Pharma aims to create greater awareness, address myths and misconceptions, and motivate millions of Indians to turn public awareness into meaningful action.

The campaign was launched at an Organ Donation Awareness Event hosted by Mankind Pharma, engaging more than 25,000 Mankindians, their families and extended communities. The event featured sessions on the realities of organ donation, myths and facts surrounding transplantation, and the current organ donation landscape in India.

The event brought together Dr D S Ray, chief nephrologist and head, renal transplant programme, R N Tagore International Institute of Cardiac Sciences, Narayana Health, Kolkata; Dr. Abhideep Chaudhary, chairman and HOD, HPB Surgery and Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi; and Dr. Kanika Rastogi, National Organ and Tissue Transplant Organisation (NOTTO), New Delhi to raise public awareness about the importance of organ donation.

“To give is to live beyond yourself. Through Angdaan Mahadaan, we want to inspire people across India to recognise the extraordinary power of a simple decision: the decision to give someone another chance at life. Our ambition is to motivate 1 crore Indians to pledge for organ donation and make this a movement that creates a lasting legacy of hope,” said Rajeev Juneja, vice chairman and managing director, Mankind Pharma Ltd.

  • Related Posts

    UP expands food, drug testing capacity across all 18 divisions

    Commissioner FSDA Roshan Jacob said recruitment of 357 Junior Analysts (Drug) had been completed, while selection for 457 Junior Analyst (Food) posts was underway to address the shortage of technical…

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott, the global healthcare leader, announced it received US Food and Drug Administration (FDA) approval and CE Mark for the UltiSynq defibrillation lead, which is designed to deliver both conduction…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Cepheid achieves CE marking under IVDR for Xpert Respiratory Panel

    Cepheid achieves CE marking under IVDR for Xpert Respiratory Panel

    Pakistan handlers behind drug, arms supply network busted in Mohali; four arrested

    Pakistan handlers behind drug, arms supply network busted in Mohali; four arrested

    Survival of a Boy from Krait Snake Bite! Unheard & Unwonted!!

    Survival of a Boy from Krait Snake Bite! Unheard & Unwonted!!